Primary Care and PCNs

Applied filters

Primary Care and PCNs

Care Setting (65)
- Adults (6)
- Care homes (11)
- Care of the elderly (6)
- Community Health Services (18)
- Dentistry (3)
- Health and Justice (15)
- Neonates (1)
- Occupational Health (3)
- Paediatrics (2)
- Palliative and End of Life Care (2)
- Primary Care and PCNs (65)
- Transfer of care (10)
- Trusts (19)
Events (13)
- Past Events (13)
Guidance (49)
- Adherence (1)
- Administering (8)
- Adverse effects (3)
- Cautions and contraindications (1)
- Complementary medicines (2)
- Dosing (2)
- Formulation (1)
- Implementation (2)
- Interactions (5)
- Legislation (3)
- Medication Safety (4)
- Patient Group Directions (14)
- Policy, Commissioning and Managerial (2)
- Polypharmacy (6)
- Prescribing (2)
- Regulatory (8)
- Supply (7)
- Swallowing difficulties (2)
- Switching (3)
- Temperature management (1)
  - Cold chain management (1)
- Unlicensed medicines (2)
Medicine (17)
- Adrenaline (2)
- Agomelatine (1)
- Alendronic acid (1)
- Amantadine (1)
- Amitriptyline (1)
- Amlodipine (1)
- Amoxicillin (1)
- Articaine + Adrenaline (1)
- Atorvastatin (1)
- Beclometasone (1)
- Beclometasone + Formoterol (1)
- Bromocriptine (1)
- Budesonide (1)
- Budesonide + Formoterol (1)
- Buprenorphine (1)
- COVID-19 vaccine (1)
- Cabergoline (1)
- Carbamazepine (2)
- Carbidopa + Levodopa + Entacapone (2)
- Cholesterol + Simvastatin (1)
- Ciclosporin (1)
- Citalopram (2)
- Clarithromycin (1)
- Co-beneldopa (1)
- Co-careldopa (1)
- Diltiazem (1)
- Doxazosin (1)
- Doxepin (1)
- Duloxetine (1)
- Entacapone (1)
- Escitalopram (1)
- Felodipine (1)
- Fentanyl (1)
- Fluoxetine (1)
- Fluticasone (1)
- Fluticasone + Formoterol (1)
- Fluticasone + Salmeterol (1)
- Fluvastatin (1)
- Fluvoxamine (1)
- Ibandronic acid (1)
- Imipramine (1)
- Influenza vaccine (1)
- Insulin aspart (1)
- Insulin aspart biphasic (1)
- Insulin degludec (1)
- Insulin degludec + Liraglutide (1)
- Insulin detemir (1)
- Insulin glargine (1)
- Insulin glulisine (1)
- Insulin human (1)
- Insulin isophane biphasic human (1)
- Insulin isophane biphasic porcine (1)
- Insulin isophane bovine (1)
- Insulin isophane human (1)
- Insulin isophane porcine (1)
- Insulin lispro (1)
- Insulin lispro biphasic (1)
- Insulin mixed bovine (1)
- Insulin protamine zinc bovine (1)
- Insulin soluble bovine (1)
- Insulin soluble human (1)
- Insulin soluble porcine (1)
- Insulin zinc crystalline human (1)
- Insulin zinc mixed human (1)
- Isocarboxazid (1)
- Levodopa (1)
- Levodopa + Carbidopa + Entacapone (2)
- Levothyroxine (1)
- Lidocaine (1)
- Lidocaine + Adrenaline (1)
- Lidocaine + Prilocaine (1)
- Lithium (1)
- Lithium carbonate (1)
- Lofepramine (1)
- Lovastatin (1)
- Mepivacaine (1)
- Mepivacaine + Adrenaline (1)
- Mesalazine (1)
- Methotrexate (3)
- Methylphenidate (1)
- Mianserin (1)
- Mirtazapine (1)
- Moclobemide (1)
- Morphine (1)
- Mycophenolate mofetil (1)
- Nifedipine (1)
- Nortriptyline (1)
- Oseltamivir (1)
- Oxycodone (1)
- Paroxetine (1)
- Pergolide (1)
- Phenelzine (1)
- Phenobarbital (1)
- Phenoxymethylpenicillin (1)
- Phenytoin (2)
- Pramipexole (1)
- Pravastatin (1)
- Prilocaine (1)
- Prilocaine + Felypressin (1)
- Primidone (1)
- Rasagiline (1)
- Reboxetine (1)
- Risedronate sodium (1)
- Ropinirole (1)
- Rosuvastatin (1)
- Rotigotine (1)
- Salbutamol (1)
- Selegiline (2)
- Senna (1)
- Sertraline (1)
- Simvastatin (1)
- Sodium valproate (1)
- Tacrolimus (1)
- Tiotropium (1)
- Tolcapone (1)
- Tramadol (1)
- Tranylcypromine (1)
- Trimipramine (1)
- Venlafaxine (1)
- Vortioxetine (1)
- Warfarin (1)
Medicines planning (3)
- Patient Group Direction Planning (3)
Publications (4)
- RMOC recommendations and resources (1)
- Research and audits (1)
- Summary advice (1)
- Templates (1)
Specialty (32)
- Cardiovascular system disorders (11)
- Diabetes (3)
- Endocrine system disorders (1)
- Infection and infectious diseases (1)
- Learning disabilities (1)
- Mental health and illness (12)
- Musculo-skeletal disorders (1)
- Neurological disorders (3)
- Reproductive health (2)
- Vaccinating (1)
Training and Development (11)
- Training and Development materials (11)

Insulin preparations: RMOC recommendations of safety considerations for formulary decision making

22 June 2018At its meeting on 18th April 2018 the Regional Medicines Optimisation Committee (RMOC) (Midlands and East) reviewed issues pertaining to safety considerations when adopting any…

Integrated Care Systems - Finding Your Way: an ‘On the Couch’ conversation

6 December 2022A practical discussion between two ICS Chief Pharmacists to share the realities, outline current challenges and consider next steps.

Learning Disability Project: Structured medication reviews - next steps

24 February 2022Developing Primary Care pharmacists to carry out Structured Medication Reviews (SMR) in adults with a learning disability who may or may not be autistic: STOMP

Managing cardiovascular disease in frail older people

2 December 2022A pragmatic approach for managing common cardiovascular long-term conditions in older people living with frailty, multimorbidity and polypharmacy

Medication Safety in Primary Care: an on the couch conversation

1 November 2022Tony Jamieson, National Clinical Improvement Lead, discussed medication safety issues with primary care pharmacy staff.

Medicines Shortages and Patient Group Directions

16 December 2019This article outlines how PGDs can be managed to allow for their continued use in cases of medicines shortages.

Memo: Drug interactions with senna or salbutamol increasing the risk of torsade de pointes

7 February 2018This memo for prescribers and pharmacy staff has been produced in response to questions from primary care prescribers and pharmacists concerned about seemingly innocuous drug combinations…

Mental health medicines: useful resources to support answering questions

3 February 2023Suggested resources to help primary care healthcare professionals find information on psychotropic and other medicines used in psychiatry

Non-acute settings with healthcare input and transcribing

22 February 2022Consideration needs to be given to the risk factors particularly associated with transcribing in non-acute settings with healthcare input

Nursing Associates, Physician Associates and the use of Patient Group Directions

16 November 2021The below summaries the legal position on the use of PGDs by Nursing Associates and Physician Associates

SPS - Specialist Pharmacy Service

NHS